Agilent Technologies, Inc. $A Shares Sold by Earnest Partners LLC

Earnest Partners LLC trimmed its position in Agilent Technologies, Inc. (NYSE:AFree Report) by 2.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 475,937 shares of the medical research company’s stock after selling 11,310 shares during the quarter. Earnest Partners LLC owned about 0.17% of Agilent Technologies worth $61,087,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Capital A Wealth Management LLC raised its position in Agilent Technologies by 10,600.0% during the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock worth $25,000 after buying an additional 212 shares during the last quarter. Davis Capital Management purchased a new stake in shares of Agilent Technologies in the 3rd quarter valued at $28,000. Physician Wealth Advisors Inc. boosted its holdings in shares of Agilent Technologies by 490.0% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after acquiring an additional 196 shares during the last quarter. State of Wyoming acquired a new stake in shares of Agilent Technologies in the second quarter worth $35,000. Finally, SJS Investment Consulting Inc. increased its stake in shares of Agilent Technologies by 2,836.4% in the third quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock worth $41,000 after acquiring an additional 312 shares during the period.

Wall Street Analysts Forecast Growth

A has been the subject of a number of research reports. Evercore upgraded shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and boosted their target price for the company from $155.00 to $160.00 in a research report on Monday, January 5th. Robert W. Baird increased their price target on Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 25th. UBS Group reduced their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Weiss Ratings reissued a “hold (c+)” rating on shares of Agilent Technologies in a report on Monday, December 29th. Finally, Barclays lowered their target price on Agilent Technologies from $165.00 to $150.00 and set an “overweight” rating on the stock in a research note on Thursday, February 26th. Two research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $161.20.

Read Our Latest Research Report on Agilent Technologies

Agilent Technologies Stock Down 0.0%

A stock opened at $111.60 on Monday. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. The firm’s fifty day moving average is $130.34 and its 200 day moving average is $135.95. The firm has a market cap of $31.54 billion, a PE ratio of 24.64, a P/E/G ratio of 2.35 and a beta of 1.31.

Agilent Technologies (NYSE:AGet Free Report) last issued its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The firm had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.81 billion. During the same quarter last year, the company posted $1.31 EPS. The company’s revenue was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, research analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.255 per share. The ex-dividend date is Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. Agilent Technologies’s dividend payout ratio is currently 22.52%.

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

See Also

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.